HealthcarePre-market
Dr Lal Path Labs declares bonus issue and interim dividend
pre-market1 source ↓written by the desknot a recommendation
- and an interim
- 1:1 bonus issue
- for FY 2025-26
- ₹7 per share
- for Q2
- ₹151 cr
- year-on-year
- 17%
- with revenues reaching
- ₹731 cr
Diagnostics services company Dr Lal Path Labs announced a 1:1 bonus issue and an interim dividend of ₹7 per share for FY 2025-26. The consolidated net profit for Q2 was ₹151 cr, up 17% year-on-year, with revenues reaching ₹731 cr, an 11% increase. This news may enhance shareholder sentiment.
Not investment advice. For informational purposes only.